Abstract || Annals of Clinical Case Reports

Major Scope

Cardiovascular Case Reports
Oncology Case Reports
Surgical Case Reports
Gastroenterological Case Reports
Neurological Case Reports
Dermatological Case Reports
Respiratory Case Reports
Obstetrics/Gynecology Case Reports
Nephrology Case Reports
Immunology Case Reports
Paediatric Case Reports
Orthopedics Case Reports
Dental Case Reports

Abstract

Citation: Ann Clin Case Rep. 2021;6(1):1988.DOI: 10.25107/2474-1655.1988

A Case Report on Phenazopyridine-Induced Hemolytic Anemia

Randolph E Regal and Nicole Farah

Department of Pharmacy, University of Michigan, USA

^*Correspondance to: Randolph E Regal

PDF Full Text Case Report | Open Access

Abstract:

This is the case of a 68 year old woman with a hematologist-confirmed case of phenazopyridineinduced hemolytic anemia. She had been using the drug for seven months at a dose of 800 mg daily for a chronic interstitial cystitis. Although an attempt was made to taper the medication to discontinuation, severe urinary pain impeded this process, and the patient could only accept a reduction in dose to 600 mg daily. Nonetheless, the hemoglobin improved from 9.1 g/dl to 10.4 g/ dl after just one month on the lower dose. Several months later, while still taking 600 mg daily, the hemoglobin continued to improve to11.9 g/dl.